Skip to content

Effect of Chronotherapy on Blood Pressure - Time of Intake of Blood Pressure Lowering Drugs

Chronotherapy in Hypertension - a Study of Blood Pressure Levels Following Intake of Antihypertensive Medication in the Morning or at Bedtime

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05322967
Enrollment
120
Registered
2022-04-12
Start date
2022-06-25
Completion date
2025-06-01
Last updated
2024-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Therapy, Hypertension, Primary Health Care

Keywords

Cross-over study

Brief summary

A randomized clinical trials with cross-over design to evaluate changes in blood pressure, renal function (creatinine, estimated glomerular filtration), LDL and HDL-cholesterol after taking antihypertensive drugs in the morning or at bedtime. Blood pressure will be estimated by ambulatory blood pressure measurements. There will be a shift in time of drug intake after 8 weeks for each participant. Approximately 100 individuals aged 40-75 years and on stable anti-hypertensive treatment and blood pressure \<150/95 mm Hg will be recruited. No new drugs will be introduced during the study.

Detailed description

High blood pressure (hypertension, HT) is very common and can lead to serious cardiovascular complications and premature death. Despite effective drug treatment many patients do not reach the blood pressure goal. No new antihypertensive drugs have been developed lately, so there is a need for other strategies to increase attainment of goals and diminish the rate of complications. The circadian rhythm can affect sleep, body temperature, hormone levels, metabolism and the effect of drugs. The impact of antihypertensive treatment in the short and long run was described in a large randomized study in primary health care where individuals with hypertension were randomly assigned to take the drugs in the morning or at bedtime. Intake at bedtime resulted in lower blood pressure, better kidney function and lower LDL-cholesterol. Further, after a mean time follow-up of 6 years a 50% reduction of cardiovascular death was seen. There was by time running a difference in antihypertensive drugs and also co-morbidity between the groups. Despite this, there is a need to investigate if chronotherapy might play a role in antihypertensive care. The aim of the study is to investigate the effect of intake of drugs in the morning compared to at bed-time. Methods: Patients 40-75 years, will be recruited from two primary health care centers and one clinic of internal medicine. Medical history, current medication will be recorded. Office blood pressure, body height and weight, ECG and ambulatory blood pressure measurement (ABPM) will be performed. Blood will be analyzed for fasting blood glucose, LDL and HDL-cholesterol and creatinine. After inclusion in the study the patients are randomly, by clinic, allocated to take their antihypertensive drugs in the morning or at bed-time during 8 week. The ordinary medication is used during the study period. The patients are instructed to keep a diary on wake-up and bed-times, side effects, sleep quality and other experiences during therapy. After 8 weeks the investigations at base-line are repeated and a visual analogue scale on sleep, daytime tiredness and urine voiding is recorded. The patients shift to intake of medication on the opposite time of day for 8 weeks. The study is completed with a repeated investigation as above. The analyses of data is performed by researchers of the team that are not aware of the patients' allocation. The diaries will be a base for later in-depth-interviews with a part of the patients. The analyses will be intention-to-treat using appropriate methods for the data. Office blood pressure, blood lipids and kidney function at baseline, 8 and 16 weeks, as well as sleep duration, urine voiding at night will be analyzed. ABPM will be analyzed using mean blood pressure around-the-clock, daytime and nighttime blood pressure, dipping and morning surge.

Interventions

OTHERTime of ordinary antihypertensive medication intake

Time of ordinary antihypertensive medication intake

Sponsors

Swedish Heart Lung Foundation
CollaboratorOTHER
Vastra Gotaland Region
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

It is not possible to mask patients, care provider or investigators but the outcome assessors are masked for allocation of patients

Intervention model description

Participants are randomized in the initial phase to take their ordinary anti-hypertensive medication in the morning or at bedtime for 8 weeks. Then the participants are switching to the alternative intervention during 8 weeks in the second phase of the study.

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of hypertension * Stable antihypertensive treatment at least 8 weeks prior to inclusion * One to four antihypertensive drugs

Exclusion criteria

* Atrial fibrillation/flutter * Diabetes * Previous stroke or TIA * Heart failure * Ischemic heart disease * Peripheral artery disease * Malignant disease with less than one year expected survival * Inability to follow study protocol (for instance shift work)

Design outcomes

Primary

MeasureTime frameDescription
24 hours blood pressure changes between 8 and 16 weeks.8 and 16 weeksAmbulatory blood pressure changes between 8 and 16 weeks. Systolic and diastolic mean blood pressure level.
Change of dipping of blood pressure between 8 and 16 weeks.8 and 16 weeksRatio between daytime and nighttime blood pressure registered after 8 and 16 weeks. Systolic and diastolic mean blood pressure level.

Secondary

MeasureTime frameDescription
Nighttime blood pressure changes between 8 and 16 weeks.8 and 16 weeksAmbulatory nighttime blood pressure registered after 8 and 16 weeks. Systolic and diastolic mean blood pressure level.
Office blood pressure changes between 8 and 16 weeks.8 and 16 weeksOffice blood pressure registered after 8 and 16 weeks. Systolic and diastolic mean blood pressure level.
Difference in morning surge of blood pressure between 8 and 16 weeks.8 and 16 weeksOccurrence of morning (yes/no)
Daytime blood pressure changes between 8 and 16 weeks.8 and 16 weeksAmbulatory daytime blood pressure registered after 8 and 16 weeks. Systolic and diastolic mean blood pressure level.
Difference in HDL cholesterol levels between 8 and 16 weeks.8 and 16 weeksHDL cholesterol changes according to time of intake of antihypertensive drugs
Difference in total cholesterol levels between 8 and 16 weeks.8 and 16 weeksTotal cholesterol changes according to time of intake of antihypertensive drugs
Difference in p-creatinine levels between 8 and 16 weeks.8 and 16 weeksP-creatinine changes according to time of intake of antihypertensive drugs
Difference in LDL cholesterol levels between 8 and 16 weeks.8 and 16 weeksLDL cholesterol changes according to time of intake of antihypertensive drugs

Other

MeasureTime frameDescription
Difference in score of Epworth sleepiness scale between 8 and 16 weeks8 and 16 weeksEpworth sleepiness scale score registered by the patients according to time of antihypertensive drug intake
Perceived side effects 16 weeks16 weeksPerceived side effects registered by the patients (VAS) according to time of antihypertensive drug intake
Perceived side effects 8 weeks8 weeksPerceived side effects registered by the patients (VAS) according to time of antihypertensive drug intake

Countries

Sweden

Contacts

Primary ContactKristina B Boström, Prof, MD
kristina.a.bengtsson@vgregion.se0702409091
Backup ContactGeorgios Mourtzinis, PhD, MD
georgios.mourtzinis@vgregion.se0735522153

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026